메뉴 건너뛰기




Volumn 16, Issue 4, 2008, Pages 291-298

The introduction of policies for human papillomavirus vaccination in Europe

Author keywords

HPV; Immunization policy; Vaccination

Indexed keywords

PLACEBO; WART VIRUS VACCINE;

EID: 48149111841     PISSN: 09431853     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10389-008-0206-9     Document Type: Review
Times cited : (5)

References (69)
  • 1
    • 0027954358 scopus 로고
    • Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening
    • H-O Adami J Pontén P Sparén R Bergström L Gustafsson LG Friberg 1994 Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening Cancer 73 140 147
    • (1994) Cancer , vol.73 , pp. 140-147
    • Adami, H.-O.1    Pontén, J.2    Sparén, P.3    Bergström, R.4    Gustafsson, L.5    Friberg, L.G.6
  • 2
    • 34548188496 scopus 로고    scopus 로고
    • Burden of cervical cancer in the 27 member states of the European Union: Estimates for 2004
    • M Arbyn P Autier J Ferlay 2007 Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004 Ann Oncol 18 1423 1425
    • (2007) Ann Oncol , vol.18 , pp. 1423-1425
    • Arbyn, M.1    Autier, P.2    Ferlay, J.3
  • 3
    • 34848895100 scopus 로고    scopus 로고
    • Burden of cervical cancer in Europe: Estimates for 2004
    • M Arbyn AO Raifu P Autier J Ferlay 2007 Burden of cervical cancer in Europe: estimates for 2004 Ann Oncol 18 1708 11715
    • (2007) Ann Oncol , vol.18 , pp. 1708-11715
    • Arbyn, M.1    Raifu, A.O.2    Autier, P.3    Ferlay, J.4
  • 5
    • 33750583314 scopus 로고    scopus 로고
    • Measles in the United Kingdom: Can we eradicate it by 2010?
    • P Asaria E MacMahon 2006 Measles in the United Kingdom: can we eradicate it by 2010? BMJ 333 890 895
    • (2006) BMJ , vol.333 , pp. 890-895
    • Asaria, P.1    MacMahon, E.2
  • 9
    • 0141960223 scopus 로고    scopus 로고
    • Viral sexually transmitted disease vaccine acceptability among college students
    • CW Boehner SR Howe DI Bernstein SL Rosenthal 2003 Viral sexually transmitted disease vaccine acceptability among college students Sex Transm Dis 30 774 778
    • (2003) Sex Transm Dis , vol.30 , pp. 774-778
    • Boehner, C.W.1    Howe, S.R.2    Bernstein, D.I.3    Rosenthal, S.L.4
  • 10
    • 38049013940 scopus 로고    scopus 로고
    • HPV and cervical cancer: Screening or vaccination?
    • FX Bosch X Castellsaguè de Sanjosè 2008 HPV and cervical cancer: screening or vaccination? Br J Cancer 98 15 21
    • (2008) Br J Cancer , vol.98 , pp. 15-21
    • Bosch, F.X.1    Castellsaguè, X.2    De Sanjosè3
  • 11
    • 48149089072 scopus 로고    scopus 로고
    • British Department of Health Press release, 20 June 2007. Available online at Accessed on February 26, 2008
    • British Department of Health (2007) Press release, 20 June 2007. Available online at http://www.gnn.gov.uk/environment/dh/. Accessed on February 26, 2008
    • (2007)
  • 12
    • 0031950458 scopus 로고    scopus 로고
    • Vaccine safety: Current and future challenges
    • RT Chen B Hibbs 1998 Vaccine safety: current and future challenges Pediatr Ann 27 445 455
    • (1998) Pediatr Ann , vol.27 , pp. 445-455
    • Chen, R.T.1    Hibbs, B.2
  • 14
    • 48149114955 scopus 로고    scopus 로고
    • Danish National Board of Health Announcement available online at. Accessed on February 28, 2008
    • Danish National Board of Health (2008) Announcement available online at http://www.sst.dk/upload/nyheder/indstillling_hpvvaccine_4okt07.pdf. Accessed on February 28, 2008
    • (2008)
  • 15
    • 23244443218 scopus 로고    scopus 로고
    • Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents
    • K Davis ED Dickman D Ferris JK Dias 2004 Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents Obstet Gynecol Surv 59 82 822
    • (2004) Obstet Gynecol Surv , vol.59 , pp. 82-822
    • Davis, K.1    Dickman, E.D.2    Ferris, D.3    Dias, J.K.4
  • 16
    • 33646832870 scopus 로고    scopus 로고
    • Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV
    • AF Dempsey GD Zimet RL Davis L Koutsky 2006 Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV Pediatrics 117 1486 1493
    • (2006) Pediatrics , vol.117 , pp. 1486-1493
    • Dempsey, A.F.1    Zimet, G.D.2    Davis, R.L.3    Koutsky, L.4
  • 17
    • 48149109705 scopus 로고    scopus 로고
    • The need for greater understanding of the economic issues
    • (to be completed)
    • Drummond M (2008) The need for greater understanding of the economic issues. J Public Health (Suppl) (to be completed)
    • (2008) J Public Health , Issue.SUPPL.
    • Drummond, M.1
  • 18
    • 48149110244 scopus 로고    scopus 로고
    • Available online at. Accessed on February 26, 2008
    • ECCA (European Cervical Cancer Association) (2008) Available online at http://www.ecca.fr/webECCA/en/. Accessed on February 26, 2008
    • (2008)
  • 19
    • 48149114586 scopus 로고    scopus 로고
    • Available online at Accessed on February 26, 2008
    • ECDC (European Centre for Disease Control) (2008) Guidance for the introduction of HPV vaccines in EU countries. Available online at http://ecdc.europa.eu/pdf/HPV_report.pdf. Accessed on February 26, 2008
    • (2008) Guidance for the Introduction of HPV Vaccines in EU Countries
  • 20
    • 48149104321 scopus 로고    scopus 로고
    • ECPC (European Cancer Patient Coalition) Available online at. Accessed on February 26, 2008
    • ECPC (European Cancer Patient Coalition) (2008) Available online at http://www.cancerworld.org/ECPC/. Accessed on February 26, 2008
    • (2008)
  • 21
    • 48149109364 scopus 로고    scopus 로고
    • Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 September 2006 to 30 September 2006
    • European Commission 27 October 2006. Available online at. Accessed February 29, 2008
    • European Commission (2006) Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 September 2006 to 30 September 2006. Official Journal of the European Union, 27 October 2006. Available online at http://eurlex.europa.eu/LexUriServ/site/en/oj/2006/c_259/ c_25920061027en00060012.pdf. Accessed February 29, 2008
    • (2006) Official Journal of the European Union
  • 23
    • 36749031153 scopus 로고    scopus 로고
    • Prevention and control of viral hepatitis through adolescent health programmes in Europe
    • D FitzSimons A Vorsters K Hoppenbrouwers P Van Damme 2007 Prevention and control of viral hepatitis through adolescent health programmes in Europe Vaccine 25 8651 8659
    • (2007) Vaccine , vol.25 , pp. 8651-8659
    • Fitzsimons, D.1    Vorsters, A.2    Hoppenbrouwers, K.3    Van Damme, P.4
  • 26
    • 48149105749 scopus 로고    scopus 로고
    • German Standing Committee on Vaccination (STIKO) March 23, 2007. Available online at. Accessed February 28, 2007
    • German Standing Committee on Vaccination (STIKO) (2007) Recommendation and explanatory statement about vaccination against Human Papilloma virus for girls of 12 to 17 years of age. March 23, 2007. Available online at http://www.rki.de/cln_049/nn_195838/DE/Content/Infekt/Impfen/ STIKO__Empfehlungen/Aktuelles/aktuelles__node.html?__nnn=true. Accessed February 28, 2007
    • (2007) Recommendation and Explanatory Statement about Vaccination Against Human Papilloma Virus for Girls of 12 to 17 Years of Age
  • 27
    • 48149094468 scopus 로고    scopus 로고
    • Greek Ministry of Health and Social Solidarity Press release, 19 October 2007. Available online at
    • Greek Ministry of Health and Social Solidarity (2007) Press release, 19 October 2007. Available online at http://www.mohaw.gr
    • (2007)
  • 30
    • 33646058566 scopus 로고    scopus 로고
    • Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial
    • on behalf of the HPV Vaccine Study group
    • DM Harper EL Franco CM Wheeler AB Moscicki B Romanowski CM Roteli-Martins D Jenkins A Schuind SA Costa Clemens G Dubin on behalf of the HPV Vaccine Study group 2006 Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial Lancet 367 1247 1255
    • (2006) Lancet , vol.367 , pp. 1247-1255
    • Harper, D.M.1    Franco, E.L.2    Wheeler, C.M.3    Moscicki, A.B.4    Romanowski, B.5    Roteli-Martins, C.M.6    Jenkins, D.7    Schuind, A.8    Costa Clemens, S.A.9    Dubin, G.10
  • 31
    • 48149089527 scopus 로고    scopus 로고
    • Health Council of the Netherlands The Hague: Health Council of the Netherlands; publication no. 2008/08. ISBN: 978-90-5549-702-7
    • Health Council of the Netherlands (2008) Vaccination against cervical cancer. The Hague: Health Council of the Netherlands; publication no. 2008/08. ISBN: 978-90-5549-702-7
    • (2008) Vaccination Against Cervical Cancer
  • 32
    • 48149105389 scopus 로고    scopus 로고
    • Available online at. Accessed on February 26, 2008
    • Health Protection Agency (UK). Annual COVER report 2004/2005. Available online at http://www.hpa.org.uk/publications/2005/HPA_protect_health_children/ full_report/protect_health_children_05may.pdf. Accessed on February 26, 2008
    • Annual COVER Report 2004/2005
  • 33
    • 48149093139 scopus 로고    scopus 로고
    • The contribution of vaccine manufacturers to the establishment of vaccination policies
    • (to be completed)
    • Hessel L (2008) The contribution of vaccine manufacturers to the establishment of vaccination policies J Public Health (Suppl) (to be completed)
    • (2008) J Public Health , Issue.SUPPL.
    • Hessel, L.1
  • 34
    • 16444385146 scopus 로고    scopus 로고
    • Acceptability of universal hepatitis B vaccination among school pupils and parents
    • A Hinds JC Cameron 2004 Acceptability of universal hepatitis B vaccination among school pupils and parents Commun Dis Public Health 7 278 282
    • (2004) Commun Dis Public Health , vol.7 , pp. 278-282
    • Hinds, A.1    Cameron, J.C.2
  • 36
    • 33947578644 scopus 로고    scopus 로고
    • Why is evidence-based medicine so harsh on vaccines? An exploration of the method and its natural biases
    • RM Jacobson PV Targonski GA Poland 2007 Why is evidence-based medicine so harsh on vaccines? An exploration of the method and its natural biases Vaccine 25 3165 3169
    • (2007) Vaccine , vol.25 , pp. 3165-3169
    • Jacobson, R.M.1    Targonski, P.V.2    Poland, G.A.3
  • 38
    • 48149095316 scopus 로고    scopus 로고
    • Available online at. Accessed on February 26, 2008
    • Jo's Trust (2008) Available online at http://www.jotrust.co.uk. Accessed on February 26, 2008
    • (2008)
  • 41
    • 33646826689 scopus 로고    scopus 로고
    • HPV vaccine and adolescents' sexual activity - It would be a shame if unresolved ethical dilemmas hampered this breakthrough
    • B Lo 2006 HPV vaccine and adolescents' sexual activity - It would be a shame if unresolved ethical dilemmas hampered this breakthrough BMJ 332 1106 1107
    • (2006) BMJ , vol.332 , pp. 1106-1107
    • Lo, B.1
  • 42
    • 34548450831 scopus 로고    scopus 로고
    • Human papillomavirus vaccination programmes
    • B Lo 2007 Human papillomavirus vaccination programmes BMJ 335 357 358
    • (2007) BMJ , vol.335 , pp. 357-358
    • Lo, B.1
  • 44
    • 0028174768 scopus 로고
    • Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease
    • JE Macgregor MK Campbell EMF Mann KY Swanson 1994 Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease BMJ 308 1407 1411
    • (1994) BMJ , vol.308 , pp. 1407-1411
    • MacGregor, J.E.1    Campbell, M.K.2    Mann, E.M.F.3    Swanson, K.Y.4
  • 45
    • 4944239359 scopus 로고    scopus 로고
    • MMR vaccination and autism: What is the evidence for a causal association?
    • KM Madsen M Vestergaard 2004 MMR vaccination and autism: what is the evidence for a causal association? Drug Saf 27 831 840
    • (2004) Drug Saf , vol.27 , pp. 831-840
    • Madsen, K.M.1    Vestergaard, M.2
  • 46
    • 33744815650 scopus 로고    scopus 로고
    • Knowledge and acceptance of human papillomavirus vaccination: Perspectives of young Australians living in Melbourne, Australia
    • A McClelland P Liamputtong 2006 Knowledge and acceptance of human papillomavirus vaccination: perspectives of young Australians living in Melbourne, Australia Sex Health 3 95 101
    • (2006) Sex Health , vol.3 , pp. 95-101
    • McClelland, A.1    Liamputtong, P.2
  • 48
    • 48149090621 scopus 로고    scopus 로고
    • The decision-making process to recommend a new vaccine. From vaccine research to policy and programme implementation - The Finnish experience
    • (to be completed)
    • Nohynek H (2008) The decision-making process to recommend a new vaccine. From vaccine research to policy and programme implementation - the Finnish experience. J Public Health (Suppl) (to be completed)
    • (2008) J Public Health , Issue.SUPPL.
    • Nohynek, H.1
  • 49
    • 48149104895 scopus 로고    scopus 로고
    • Available online at. Accessed on February 26, 2008
    • O.N.Da (Osservatorio Nazionale sulla salute della Donna) (2008) Available online at http://www.ondaosservatorio.it/inglese/index.html. Accessed on February 26, 2008
    • (2008)
  • 52
    • 48149089548 scopus 로고    scopus 로고
    • Portugese Government Transcript available at: Accessed on February 26, 2008
    • Portugese Government (2007) Declaration of the Prime-Minister before the Parliament. Transcript available at: http://www.governo.gov.pt/Portal/PT/ Primeiro_Ministro/Intervencoes/20071106_PM_Int_OE_AR.htm. Accessed on February 26, 2008
    • (2007) Declaration of the Prime-Minister before the Parliament
  • 53
    • 48149100248 scopus 로고    scopus 로고
    • Public Health Economics of Vaccines in the Netherlands methodological issues and applications
    • (to be completed)
    • Postma MJ (2008) Public Health Economics of Vaccines in the Netherlands methodological issues and applications. J Public Health (Suppl) (to be completed)
    • (2008) J Public Health , Issue.SUPPL.
    • Postma, M.J.1
  • 54
    • 34548452644 scopus 로고    scopus 로고
    • Challenges of implementing human papillomavirus (HPV) vaccination policy
    • AE Raffle 2007 Challenges of implementing human papillomavirus (HPV) vaccination policy BMJ 335 375 377
    • (2007) BMJ , vol.335 , pp. 375-377
    • Raffle, A.E.1
  • 55
    • 48149097714 scopus 로고    scopus 로고
    • The public perception of the value of vaccines
    • (to be completed)
    • Siegrist CA, Balinska MA (2008) The public perception of the value of vaccines. J Public Health (Suppl) (to be completed)
    • (2008) J Public Health , Issue.SUPPL.
    • Siegrist, C.A.1    Balinska, M.A.2
  • 56
    • 34249339395 scopus 로고    scopus 로고
    • Vaccinating young adults against human papillomavirus: The importance of understanding health decision-making and behaviour
    • SR Skinner M Kang SL Rosenthal 2007 Vaccinating young adults against human papillomavirus: the importance of understanding health decision-making and behaviour Sexual Health 4 129 132
    • (2007) Sexual Health , vol.4 , pp. 129-132
    • Skinner, S.R.1    Kang, M.2    Rosenthal, S.L.3
  • 57
    • 34249654115 scopus 로고    scopus 로고
    • Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ:a combined analysis of four randomised clinical trials
    • The FUTURE II Study Group
    • The FUTURE II Study Group 2007 Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ:a combined analysis of four randomised clinical trials Lancet 369 1861 1868
    • (2007) Lancet , vol.369 , pp. 1861-1868
  • 58
    • 0033783341 scopus 로고    scopus 로고
    • Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness
    • M Van Ballegooijen M van den Akker-van J Patnick E Lynge M Arbyn A Anttila G Ronco J Dik F Habbema 2000 Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness Eur J Cancer 36 2177 2188
    • (2000) Eur J Cancer , vol.36 , pp. 2177-2188
    • Van Ballegooijen, M.1    Van Den Akker-Van, M.2    Patnick, J.3    Lynge, E.4    Arbyn, M.5    Anttila, A.6    Ronco, G.7    Dik, J.8    Habbema, F.9
  • 61
    • 48149090469 scopus 로고    scopus 로고
    • Spanish Ministry of Health and Consumption Press release, 10 October 2007
    • Spanish Ministry of Health and Consumption (2007) Press release, 10 October 2007
    • (2007)
  • 62
    • 48149108332 scopus 로고    scopus 로고
    • Available online at. Accessed February 28, 2008
    • Swedish Pharmaceutical Benefits Board (LFN) (2007) Available online at http://www.lfn.se/LFNTemplates/Ptjanst____1534.aspx. Accessed February 28, 2008
    • (2007)
  • 63
    • 48149100852 scopus 로고    scopus 로고
    • Swedish National Board of Health and Welfare Press release. Available at. Accessed February 28, 2008
    • Swedish National Board of Health and Welfare (Socialstyrelsen) (2008) Press release. Available at http://www.socialstyrelsen.se/Aktuellt/Nyheter/2008/ Q1/press080226.htm. Accessed February 28, 2008
    • (2008)
  • 66
    • 33646556318 scopus 로고    scopus 로고
    • Health Technology Assessment - An Introduction to objectives, role of evidence and structure in Europe
    • available on. Accessed on February 2008
    • Velasco-Garrido M, Busse R (2005) Health Technology Assessment - An Introduction to objectives, role of evidence and structure in Europe. European Observatory on Health Systems and Policies, available on http://www.eunethta. net/HTA/HTA_Networks/. Accessed on February 2008
    • (2005) European Observatory on Health Systems and Policies
    • Velasco-Garrido, M.1    Busse, R.2
  • 69
    • 34250217862 scopus 로고    scopus 로고
    • Public health, public trust and lobbying
    • MK Wynia 2007 Public health, public trust and lobbying Am J Bioethics 7 4 7
    • (2007) Am J Bioethics , vol.7 , pp. 4-7
    • Wynia, M.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.